Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» Big Pharma and cell & molecular biology

Most Recent

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Ubiquitin basics

Ubiquitin basics

By | July 1, 2012

Despite its discovery as a protein that seems to show up everywhere, at least in eukaryotic cells, researchers are only beginning to scratch the surface of all of the cellular functions involving ubiquitin. 

0 Comments

image: Flower Barcodes

Flower Barcodes

By | June 28, 2012

Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.

1 Comment

image: Roundup from Microbiology Meeting

Roundup from Microbiology Meeting

By | June 21, 2012

Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.

0 Comments

image: Stem Cells from Corpses

Stem Cells from Corpses

By | June 15, 2012

Researchers pull viable cells from bodies that had been dead for more than 2 weeks.

1 Comment

image: Older Dads Have Healthier Kids?

Older Dads Have Healthier Kids?

By | June 11, 2012

New research finds that older men have children and grandchildren with longer telomeres, possibly pointing to health benefits of delayed reproduction.

4 Comments

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Grading on the Curve

Grading on the Curve

By | June 1, 2012

Actin filaments respond to pressure by forming branches at their curviest spots, helping resist the push.

5 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. A Scrambled Mess
    Features A Scrambled Mess

    Why do so many human eggs have the wrong number of chromosomes?

Advertisement
Advertisement
RayBioTech